can retatrutide cause anxiety Retatrutide, an experimental weight-loss drug, has not been approved by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation Is a new weight-loss drug

Following the July 2025 CVS Caremark formulary change, we observed an immediate increase in switching from AOM tirzepatide, while patients with an active supply of AOM semaglutide showed stable or even slightly reduced switching during the same period, consistent with its designation as the preferred option

Lessening of hyperpigmentation, melasma and sun-induced dark spots

Specifically, study participants taking GLP-1 drugs had a 10% lower risk of depression than participants taking DPP4i medication

We'll evaluate your history, screen for contraindications, and recommend the right dose

The difference is mainly in how insurance treats the prescription and which indication your provider uses when prescribing it

Semaglutide users in major trials experienced average weight reductions of 15 to 22 percent of body weight, compared to much smaller losses with metformin